Evidence map›Paper›PMID 28420644›Full record

Trial reportJournal of the American Heart Association2017

Smokers and Postcessation Weight Gain After Acute Coronary Syndrome.

Payam Dehghani, Bettina Habib, Sarah B Windle, Nathalie Roy, Wayne Old, François R Grondin, Iqbal Bata, Ayman Iskander, Claude Lauzon, Nalin Srivastava and 10 more

Registry-linked trialOpen access · goldAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of the American Heart Association, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00794573 (Evaluation of Varenicline), which is not on this map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00794573 phase3completednot on this map

Evaluation of Varenicline (Champix) in Smoking Cessation for Patients Post-Acute Coronary Syndrome (EVITA) Trial

TypeinterventionalSponsorMark EisenbergRan2009 to 2015Enrolled302ConditionsAcute Coronary SyndromeArmsvarenicline, placebo
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 9 citations in OpenAlex.

  1. Nicotine receptor partial agonists for smoking cessation.The Cochrane database of systematic reviews · 2023
    Pooled it
  2. Interventions for preventing weight gain after smoking cessation.The Cochrane database of systematic reviews · 2021
    Pooled it
  3. Trial
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 16 institutions in 2 countries.

Payam DehghaniPrairie Vascular Research Network, University of Saskatchewan, Regina, Canada.
Bettina HabibDivision of Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital/McGill University, Montréal, Quebec, Canada.
Sarah B WindleDivision of Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital/McGill University, Montréal, Quebec, Canada.
Nathalie RoyCentre de santé et de services sociaux de Chicoutimi, Chicoutimi, Quebec, Canada.
Wayne OldSentara Cardiovascular Research Institute, Norfolk, VA.
François R GrondinCISSS Chaudière-Appalaches, Hôtel-Dieu de Lévis site, Lévis, Quebec, Canada.
Iqbal BataQueen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada.
Ayman IskanderSJH Cardiology Associates and St. Joseph's Hospital, Liverpool, NY.
Claude LauzonCISSS - Chaudière-Appalaches, Thetford Mines, Quebec, Canada.
Nalin SrivastavaSpartanburg Regional Medical Center, Spartanburg, SC.
Adam ClarkeValley Regional Hospital, Kentville, Nova Scotia, Canada.
Daniel CassavarProMedica Toledo Hospital, Toledo, OH.
Danielle DionCISSS de Chaudière Appalaches site Hôpital St-Georges, Beauce, Quebec, Canada.
Herbert HaughtHeart Center Research, Huntsville, AL.
Shamir R MehtaHamilton Health Sciences, Hamilton, Ontario, Canada.
Jean-François BarilDr. Georges-L.-Dumont University Hospital Centre, Moncton, New Brunswick, Canada.
Charles LambertFlorida Hospital Pepin Heart Institute, Tampa, FL.
Mina MadanSunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Beth L AbramsonSt. Michael's Hospital, Toronto, Ontario, Canada.
Mark J EisenbergDivision of Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital/McGill University, Montréal, Quebec, Canada mark.eisenberg@mcgill.ca.
Centre intégré de santé et de services sociaux de Chaudière-Appalaches · CAMcGill University · CAAdventHealth Tampa · USCentre de Santé et de Services Sociaux de Chicoutimi · CADr. Georges-L.-Dumont University Hospital Centre · CAHamilton Health Sciences · CAHuntsville Hospital · USJewish General Hospital · CAProMedica Toledo Hospital · USQueen Elizabeth II Health Sciences Centre · CASentara Heart Hospital · USSpartanburg Regional Medical Center · USSt. Joseph's Hospital · USSt. Michael's Hospital · CASunnybrook Health Science Centre · CAUniversity of Saskatchewan · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSmoking cessation and weight management are recommended after acute coronary syndrome (ACS); however, little is known about the effects of smoking cessation on weight change after ACS. We aimed to assess the effect of smoking cessation after ACS on weight over a 12-month follow-up period. METHODS AND

resultsData were prospectively collected from the EVITA (Evaluation of Varenicline in Smoking Cessation for Patients Post-Acute Coronary Syndrome) trial. Weight change was compared among 3 groups of patients: those who were completely abstinent (n=70), those who smoked intermittently (n=68), and those who smoked persistently (n=34). Patients' mean baseline weight was 83.9 kg (SD 17.7) with a mean body mass index of 28.5 (SD 5.4). Patients smoked a mean of 37.7 years (SD 17.7) and a mean of 21.0 cigarettes (SD 9.0) per day prior to their ACS. Weight change varied across groups, with abstainers gaining a mean of 4.8 kg (SD 8.6), intermittent smokers gaining a mean of 2.0 kg (SD 8.9) and persistent smokers losing a mean of 0.7 kg (SD 7.4). At 52 weeks, abstainers were more likely to gain weight than persistent smokers (difference in means 5.5 kg; 95% CI 2.3-8.8). This weight gain was not associated with an increase in the use of antihypertensive or antidiabetic medications.

conclusionsFollowing an ACS, significant weight is gained by patients who quit smoking. Weight-management interventions among smokers who quit after ACS should be a focus of investigation in future research so that the cardiovascular benefits achieved by smoking cessation are not offset by weight gain in this high-risk population. CLINICAL

trial registrationURL: http://www.clinicaltrials.gov. Unique identifier: NCT00794573.

Indexed as

Risk Reduction BehaviorSmoking PreventionWeight GainAcute Coronary SyndromeAgedBlood PressureBody Mass IndexDouble-Blind MethodFemaleHumansMaleMiddle AgedNicotinic AgonistsProspective StudiesRecurrenceRisk FactorsNicotinic AgonistsVareniclineacute coronary syndromesecondary preventionsmokingweight gain

Identifiers

PMID28420644
PMCPMC5532997
OpenAlexW2606045244

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.